前收市價 | 23.50 |
開市 | 23.60 |
買盤 | 23.97 x 100 |
賣出價 | 24.21 x 200 |
今日波幅 | 23.60 - 24.46 |
52 週波幅 | 10.41 - 27.93 |
成交量 | |
平均成交量 | 42,443 |
市值 | 264.42M |
Beta 值 (5 年,每月) | 0.76 |
市盈率 (最近 12 個月) | 185.38 |
每股盈利 (最近 12 個月) | 0.13 |
業績公佈日 | 2024年5月07日 |
遠期股息及收益率 | 無 (無) |
除息日 | 2016年9月07日 |
1 年預測目標價 | 24.17 |
The decline in sales of Ingevity (NGVT) is predominantly due to the repositioning of the Performance Chemicals unit in Q1.
Softer pricing hurts Ashland (ASH) sales for the fiscal second quarter.
With all the turbulence in the stock market at this time, it’s imperative to consider theimpact of analyst downgrades to minimize risk. Following a momentous AI-powered rally in the past year or so, the market’s taking a breather. Moreover, with inflation coming in hot this month again, expect the stock market to shed more of its gains in the near term. Hence, with all the uncertainty, investors must consider price target cuts from Wall-Street. With that said, here are three stocks with analyst